Literature DB >> 20669275

Who was the man who discovered the "Lewy bodies"?

Antonio M Rodrigues e Silva1, Felix Geldsetzer, Bernd Holdorff, Friedrich W Kielhorn, Monika Balzer-Geldsetzer, Wolfgang H Oertel, Howard Hurtig, Richard Dodel.   

Abstract

In 1912, Fritz Heinrich Lewy described neuronal inclusions in the brain of patients who had suffered from Paralysis agitans (i.e., Parkinson's disease). Later, these findings became the so-called "Lewy bodies." However, little is known about the man who made this discovery. Our aim was to investigate Lewy's private and professional life and to gather information for a detailed biography. We contacted over 100 archives, libraries, and museums in Germany, Poland, Switzerland, United Kingdom, and United States. Over 300 documents, publications, and photos were collected. Lewy was born in Berlin, Germany in 1885 and lived there until 1933. After his dismissal on racial grounds by the Nazis, Lewy emigrated to England in 1933 and to the United States of America in 1934, where he lived and worked until his death in 1950. This article gives a summary of Lewy's life and briefly presents his contribution to German and American neurology.
© 2010 Movement Disorder Society.

Entities:  

Mesh:

Year:  2010        PMID: 20669275     DOI: 10.1002/mds.22956

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  15 in total

Review 1.  α-Synuclein pathology in Parkinson's disease and related α-synucleinopathies.

Authors:  Michael X Henderson; John Q Trojanowski; Virginia M-Y Lee
Journal:  Neurosci Lett       Date:  2019-06-03       Impact factor: 3.046

Review 2.  Targeting the chameleon: a focused look at α-synuclein and its roles in neurodegeneration.

Authors:  Blanca A Silva; Leonid Breydo; Vladimir N Uversky
Journal:  Mol Neurobiol       Date:  2012-09-01       Impact factor: 5.590

Review 3.  [Persecuted and forgotten? The neurologists Kurt Goldstein and Friedrich Heinrich Lewy].

Authors:  Michael Martin; Heiner Fangerau; Axel Karenberg
Journal:  Nervenarzt       Date:  2022-10-05       Impact factor: 1.297

Review 4.  Parkinson's disease.

Authors:  Timothy R Mhyre; James T Boyd; Robert W Hamill; Kathleen A Maguire-Zeiss
Journal:  Subcell Biochem       Date:  2012

Review 5.  Centenary of Lewy bodies (1912-2012).

Authors:  Bernd Holdorff; Antonio M Rodrigues e Silva; Richard Dodel
Journal:  J Neural Transm (Vienna)       Date:  2013-03-02       Impact factor: 3.575

Review 6.  Alpha-synuclein and intracellular trafficking: impact on the spreading of Parkinson's disease pathology.

Authors:  Sibylle E Eisbach; Tiago F Outeiro
Journal:  J Mol Med (Berl)       Date:  2013-04-25       Impact factor: 4.599

7.  100 years of Lewy pathology.

Authors:  Michel Goedert; Maria Grazia Spillantini; Kelly Del Tredici; Heiko Braak
Journal:  Nat Rev Neurol       Date:  2012-11-27       Impact factor: 42.937

8.  α-Synuclein as CSF and Blood Biomarker of Dementia with Lewy Bodies.

Authors:  Kensaku Kasuga; Masatoyo Nishizawa; Takeshi Ikeuchi
Journal:  Int J Alzheimers Dis       Date:  2012-09-26

9.  Microglial activation and antioxidant responses induced by the Parkinson's disease protein α-synuclein.

Authors:  Dawn Béraud; Hannah A Hathaway; Jordan Trecki; Sergey Chasovskikh; Delinda A Johnson; Jeffrey A Johnson; Howard J Federoff; Mika Shimoji; Timothy R Mhyre; Kathleen A Maguire-Zeiss
Journal:  J Neuroimmune Pharmacol       Date:  2012-10-10       Impact factor: 4.147

Review 10.  Parkinson's disease-implicated kinases in the brain; insights into disease pathogenesis.

Authors:  Nicolas Dzamko; Jinxia Zhou; Yue Huang; Glenda M Halliday
Journal:  Front Mol Neurosci       Date:  2014-06-24       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.